Just weeks after filing for FDA approval of its Galleri blood test for cancer screening, Grail has reported that a flagship trial of the technology in the UK failed to achieve its primary objective.

DeepSeek allegedly targeted Claude’s reasoning capabilities, while generating ‘censorship-safe alternatives to politically sensitive questions.’ DeepSeek allegedly targeted Claude’s reasoning ...

Shares of Caterpillar, the maker of mining and construction machinery, are up more than 30% since year-end, making it the biggest contributor to the Dow Jones Industrial Average. WSJ’s Jonathan Weil ...

Global militaries are desperate to gain an advantage in the escalating AI race, as rapid developments in largescale data analysis, robotics, and large language models increase the effectiveness of ...

U.S. artificial-intelligence startup Anthropic said three Chinese AI companies set up more than 24,000 fraudulent accounts with its Claude AI model to help their own systems catch up. The three ...

OpenAI CEO Sam Altman addressed concerns about AI’s environmental impact this week while speaking at an event hosted by The Indian Express. For one thing, Altman — who was in India for a major AI ...

OpenAI CEO also downplayed concerns about how much water datacenters require at AI summit in India The OpenAI boss, Sam Altman, has tried to ease concerns about how much power is used by artificial ...

Anthropic is accusing three Chinese AI companies of setting up more than 24,000 fake accounts with its Claude AI model to improve their own models. The accusations come amid debates over how strictly ...

Mr. Ford is an essayist and a technologist. On weekday evenings, heading home on the subway from Union Square in New York City, I log into an A.I. tool from my phone and write a prompt. “Look at the ...

WASHINGTON, Feb 23 (Reuters) - Chinese AI startup DeepSeek's latest AI model, set to be released as soon as next week, was trained on Nvidia's (NVDA.O), opens new tab most advanced AI chip, the ...